Objective: To analyze the relationship between islet β-cell function and glucose fluctuation and different glucose control levels in patients with type 2 diabetes mellitus(T2DM). Methods: 99 patients with T2DM from January 2016 to March 2017 in our institution were selected, all the patients received oral glucose tolerance test (OGTT) or 100 g standard steamed bread meal test, and the standard deviation of blood glucose (SDBG) was calculated according to the results of fingertip blood glucose monitoring, which indicateed the patient's glucose fluctuation. The patient's islet β-cell function was indicated in terms of CPR index with,SUIT,FCP,CP2h. The relationship of CPR index,SUIT,FCP,CP 2 h and SDBG were analyzed. The patients were divided into 3 groups according to their HbA1c level to analyze the difference of islet β-cell functionbetween the three groups. Results: The relationship of CPR index with SUIT0、SUIT120、FCP,CP 2 h and SDBG was negatively correlatied; CPR index,SUIT,FCP and CP 2 h are decreased with the increase of blood glucose. Conclusion: The pancreatic β-cell function and glucose fluctuation in patients with T2DM have a significant correlation, the worse the blood glucose control, the worse the islet β-cell function. |
[1] WEYER C,BOGARDUS C,MOTT D M,et al.The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus[J].J Clin Invest,1999,104(6) 787-794.
[2] 吕丽芳,王椿,刘关键,等.自我血糖监测对预测糖调节异常者与糖尿病患者的日内血糖波动的价值[J].四川大学学报:医学版,2011,42(01):95-100.
[3] FUNAKOSHI S,FUJIMOTO S,HAMASAKI A,et al.Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes:Association with body mass index and duration of diabetic exposure[J].Diabetes Res Clin Pract,2008,82(3):353-358.
[4] YAMADA Y,FUKUDA K,FUJIMOTO S,et al.SUIT,secretory units of islets in transplantation:An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes[J].Diabetes Res Clin Pract,2006,74(3):222-226.
[5] SAISHO Y,TANAKA K,ABE T,et al.Effect of obesity on declining beta cell function after diagnosis of type 2 diabetes:A possible link suggested by cross-sectional analysis[J].Endocr J,2012,59(3):187-195.
[6] LEAHY J L,HIRSCH I B,PETERSON K A,et al.Targeting beta cell function early in the course of therapy for type 2 diabetes mellitus[J].J Clin Endocrinol Metab,2010,95(9):4206-4216.
[7] TURNER R C,HOLMAN R R,CULL C A,et al.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33).UK prospective diabetes study (UKPDS) group[J].Lancet 1998,352(9131):837-853.
[8] 申虎威,李燕,邢莉,等.血糖波动与糖尿病大血管病变的相关研究[J].中国病理生理杂志,2010,26(07):1311-1315.
[9] PALAZZO P,MAGGIO P,ALTAVILLAR,et al.Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients,with short-term disease[J].PLoS One,2013,8(12):e83287.
[10] 朱震宏,蒋晓真.2型糖尿病患者血糖波动与周围神经传导速度分析的观察[J].中国糖尿病杂志,2013,21(09):792-793.
[11] NAVARRO J F,MORA C.Role of inflammation in diabetic complications[J].Nephrol Dial Transplant,2005,20(12):2601-2604.
[12] DONATH M Y,SHOELSON S E.Type 2 diabetes as an inflammatory disease[J].Nat Rev Immunol,2011,11(2):98-107.
[13] EHSES J A,PERREN A,EPPLER E,et al.Increased number of islet-associated macrophages in type 2 diabetes[J].Diabetes,2007,56(9):2356-2370.
[14] BROWNLEE M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-820.
[15] BROWNLEE M.The pathobiology of diabetic complications:A unifying mechanism[J].Diabetes,2005,54(6):1615-1625.
[16] DEFRONZO R A,TOBIN J D,ANDRES R.Glucose clamp technique:A method for quantifying insulin secretion and resistance[J].Am J Physiol,1979,237(3):E214-223. |